Tianhong CNI BIOMEDICINE ETF (159859) Latest Quote at RMB 0.39; Assets Grew RMB 420 Million Over Past Half Year

NewTimeSpace (newtimespace.com) News, as of 14:21 on August 24, 2026, the CNI Biomedicine Index (399441) fell 5.47%, and the Tianhong CNI BIOMEDICINE ETF (159859) last quote stood at RMB 0.39.

In terms of liquidity, the Tianhong CNI BIOMEDICINE ETF recorded an intraday turnover rate of 7.69%, with turnover of RMB 310 million. Looking at a longer time frame, as of August 21, the ETF's average daily turnover over the past 1 week was RMB 302 million.

In terms of scale, the Tianhong CNI BIOMEDICINE ETF's assets grew RMB 420 million over the past half year, achieving notable growth. (Data source: Wind)

In terms of units, the Tianhong CNI BIOMEDICINE ETF's units increased by 428 million over the past half year, achieving notable growth. (Data source: Wind)

Data shows that leveraged funds continued to build positions. The Tianhong CNI BIOMEDICINE ETF's net margin buying on the previous trading day reached RMB 4.6446 million, and its latest margin balance stood at RMB 143 million. (Data source: Wind)

As of August 21, the Tianhong CNI BIOMEDICINE ETF's net value rose 28.94% over the past 2 years. In terms of return capability, as of August 21, 2026, since its inception, the Tianhong CNI BIOMEDICINE ETF posted a maximum single-month return of 27.87%, the longest streak of consecutive monthly gains was 5 months, with the largest cumulative advance during that streak at 31.58%, and an average return in up months of 5.32%. As of August 21, 2026, the ETF's annualized excess return over its benchmark over the past 3 months was 7.55%.

In terms of drawdown, as of August 21, 2026, over the past half year the Tianhong CNI BIOMEDICINE ETF's drawdown relative to its benchmark was 0.08%, the smallest among comparable funds. The number of days to recover from the drawdown was 37 days.

In terms of fees, the Tianhong CNI BIOMEDICINE ETF has a management fee rate of 0.50% and a custodian fee rate of 0.10%.

In terms of tracking precision, as of August 21, 2026, the Tianhong CNI BIOMEDICINE ETF's tracking error over the past 2 years was 0.034%.

The Tianhong CNI BIOMEDICINE ETF closely tracks the CNI Biomedicine Index. The CNI Biomedicine Index takes listed companies related to the biomedicine industry across the Shanghai, Shenzhen, and Beijing exchanges as its sample universe, and selects the top 30 securities based on a composite ranking of market capitalization and liquidity as index constituents, reflecting the overall performance of the biomedicine industry and providing the market with an index-based investment vehicle for this sub-sector.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.